Plandai Biotechnology, Inc. Announces Rescission of Material Definitive Agreement with Good Salt, LLC
SAN DIEGO, CA / ACCESSWIRE / August 1, 2023 / Plandai Biotechnology, Inc. ("Plandai" or the "Company") (OTC:PLPL) announces today the rescission of a material...
Third-Party Valuation Firm Provides Estimated Valuation of ByoPlanet’s (A Subsidiary Of Plandai – $PLPL) Business and Assets
ATHENS, GA / ACCESSWIRE / May 31, 2023 / ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. (the "Company,") (OTC PINK:PLPL), a leading innovator...
Byoplanet Unveils Bold Roadmap for the Upcoming Year, Under the Leadership of CEO Rick O’Shea
ATHENS, GA / ACCESSWIRE / May 31, 2023 / ByoPlanet (OTC PINK:PLPL), a wholly owned subsidiary of Plandai Biotechnology, Inc. and a leading provider of...
ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology
ATHENS, GA / ACCESSWIRE / May 17, 2023 / Plandai Biotechnology, Inc. (OTC PINK:PLPL), a Nevada corporation ("PLPL" or "Plandai"), GOOD SALT, LLC, a Florida...
Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC
SAN DIEGO, CA / ACCESSWIRE / March 20, 2023 / Plandai Biotechnology, Inc. (OTC PINK:PLPL) announces it has entered into a binding memorandum of understanding...